Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Rituximab 375 / Bendamustine 90, indolent B-non-Hodgkin Lymphoma and Mantle Cell Lymphoma, first-line

Protocol-ID: 271 V1.0 (Mini), R-BENDA (RITU375/BEND90), ind. B-NHL, MCL, first line

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
  • Mantle Cell Lymphoma; ICD-10 C83.1
  • NHL, B-Cell Type, Follicular Grade I-IIIa; ICD-10 C82.9
  • NHL, B-Cell Type, Indolent
  • NHL, B-Cell Type, Lymphoplasmocytic / Waldenström's disease; ICD-10 C88.0-
  • NHL, B-Cell Type, Marginal Zone Lymphoma; ICD-10 C83.0
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 29.12.2014